Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) FCF Margin: 2011-2025

Historic FCF Margin for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to 25.62%.

  • Mimedx Group's FCF Margin rose 248.00% to 25.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.98%, marking a year-over-year increase of 71.00%. This contributed to the annual value of 18.76% for FY2024, which is 851.00% up from last year.
  • Latest data reveals that Mimedx Group reported FCF Margin of 25.62% as of Q3 2025, which was up 77.41% from 14.44% recorded in Q2 2025.
  • Mimedx Group's FCF Margin's 5-year high stood at 25.62% during Q3 2025, with a 5-year trough of -22.53% in Q4 2021.
  • Its 3-year average for FCF Margin is 14.49%, with a median of 15.26% in 2023.
  • In the last 5 years, Mimedx Group's FCF Margin soared by 2,514bps in 2023 and then plummeted by 1,059bps in 2025.
  • Mimedx Group's FCF Margin (Quarterly) stood at -22.53% in 2021, then spiked by 1,407bps to -8.46% in 2022, then spiked by 1,864bps to 10.18% in 2023, then spiked by 975bps to 19.93% in 2024, then surged by 248bps to 25.62% in 2025.
  • Its FCF Margin was 25.62% in Q3 2025, compared to 14.44% in Q2 2025 and 5.58% in Q1 2025.